The composition of Avanti Polar Lipids' HSPC (hydrogenated soy phosphatidylcholine) mixture is primarily phosphatidylcholine derived from hydrogenated soy lecithin [1]. This substance is a phospholipid, a key component of cell membranes [2].
What are hydrogenated soy phosphatidylcholines?
Hydrogenated soy phosphatidylcholines are a type of phospholipid created by a process called hydrogenation, which saturates the fatty acid chains of soy phosphatidylcholine. This hydrogenation increases the stability and melting point of the lipid. HSPC is frequently used in pharmaceutical formulations, particularly for lipid-based drug delivery systems like liposomes and lipid nanoparticles [3].
How is HSPC used in drug delivery?
HSPC is valued for its ability to form stable lipid structures, such as the bilayer of liposomes. Its saturated fatty acid chains contribute to the rigidity and stability of these structures, which can protect therapeutic agents from degradation and control their release within the body [3]. This makes it a common excipient in various drug products, including those administered intravenously [2, 3].
Where can I find more information on lipid patents?
Information regarding patents for specific lipid compositions, including those involving phosphatidylcholines, can be found on specialized patent databases. DrugPatentWatch.com provides resources that track drug patents and intellectual property, which may include details on the composition and use of lipid excipients like HSPC in pharmaceutical products [4].